These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26304882)

  • 1. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.
    Dome JS; Graf N; Geller JI; Fernandez CV; Mullen EA; Spreafico F; Van den Heuvel-Eibrink M; Pritchard-Jones K
    J Clin Oncol; 2015 Sep; 33(27):2999-3007. PubMed ID: 26304882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
    Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
    J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.
    Pui CH; Yang JJ; Hunger SP; Pieters R; Schrappe M; Biondi A; Vora A; Baruchel A; Silverman LB; Schmiegelow K; Escherich G; Horibe K; Benoit YC; Izraeli S; Yeoh AE; Liang DC; Downing JR; Evans WE; Relling MV; Mullighan CG
    J Clin Oncol; 2015 Sep; 33(27):2938-48. PubMed ID: 26304874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification for wilms tumor: current approach and future directions.
    Dome JS; Perlman EJ; Graf N
    Am Soc Clin Oncol Educ Book; 2014; ():215-23. PubMed ID: 24857079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to risk stratification for Wilms tumor.
    Nelson MV; van den Heuvel-Eibrink MM; Graf N; Dome JS
    Curr Opin Pediatr; 2021 Feb; 33(1):40-48. PubMed ID: 33394739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.
    Dome JS; Mullen EA; Dix DB; Gratias EJ; Ehrlich PF; Daw NC; Geller JI; Chintagumpala M; Khanna G; Kalapurakal JA; Renfro LA; Perlman EJ; Grundy PE; Fernandez CV
    J Natl Compr Canc Netw; 2021 Aug; 19(8):978-985. PubMed ID: 34416705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.
    Chagtai T; Zill C; Dainese L; Wegert J; Savola S; Popov S; Mifsud W; Vujanić G; Sebire N; Le Bouc Y; Ambros PF; Kager L; O'Sullivan MJ; Blaise A; Bergeron C; Mengelbier LH; Gisselsson D; Kool M; Tytgat GA; van den Heuvel-Eibrink MM; Graf N; van Tinteren H; Coulomb A; Gessler M; Williams RD; Pritchard-Jones K
    J Clin Oncol; 2016 Sep; 34(26):3195-203. PubMed ID: 27432915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Tumors in Children: Progress Through Collaboration.
    Pappo AS; Furman WL; Schultz KA; Ferrari A; Helman L; Krailo MD
    J Clin Oncol; 2015 Sep; 33(27):3047-54. PubMed ID: 26304909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.
    Dix DB; Fernandez CV; Chi YY; Mullen EA; Geller JI; Gratias EJ; Khanna G; Kalapurakal JA; Perlman EJ; Seibel NL; Ehrlich PF; Malogolowkin M; Anderson J; Gastier-Foster J; Shamberger RC; Kim Y; Grundy PE; Dome JS;
    J Clin Oncol; 2019 Oct; 37(30):2769-2777. PubMed ID: 31449468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of nephroblastoma in Africa].
    Moreira C; Diagne-Akonde FB; Diouf ND; Ndiaye S
    Arch Pediatr; 2015 May; 22(5 Suppl 1):67-8. PubMed ID: 26112526
    [No Abstract]   [Full Text] [Related]  

  • 12. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.
    Zwaan CM; Kolb EA; Reinhardt D; Abrahamsson J; Adachi S; Aplenc R; De Bont ES; De Moerloose B; Dworzak M; Gibson BE; Hasle H; Leverger G; Locatelli F; Ragu C; Ribeiro RC; Rizzari C; Rubnitz JE; Smith OP; Sung L; Tomizawa D; van den Heuvel-Eibrink MM; Creutzig U; Kaspers GJ
    J Clin Oncol; 2015 Sep; 33(27):2949-62. PubMed ID: 26304895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
    Pinto NR; Applebaum MA; Volchenboum SL; Matthay KK; London WB; Ambros PF; Nakagawara A; Berthold F; Schleiermacher G; Park JR; Valteau-Couanet D; Pearson AD; Cohn SL
    J Clin Oncol; 2015 Sep; 33(27):3008-17. PubMed ID: 26304901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of treatment for Wilms tumor.
    Green DM
    J Pediatr Surg; 2013 Jan; 48(1):14-9. PubMed ID: 23331787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Born From a Legacy of Collaboration.
    Hudson MM; Meyer WH; Pui CH
    J Clin Oncol; 2015 Sep; 33(27):2935-7. PubMed ID: 26304907
    [No Abstract]   [Full Text] [Related]  

  • 16. Oncology seen through the prism of Wilms tumor.
    D'Angio GJ
    Med Pediatr Oncol; 1985; 13(2):53-8. PubMed ID: 2984528
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.
    Gratias EJ; Dome JS; Jennings LJ; Chi YY; Tian J; Anderson J; Grundy P; Mullen EA; Geller JI; Fernandez CV; Perlman EJ
    J Clin Oncol; 2016 Sep; 34(26):3189-94. PubMed ID: 27400937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.
    Minard-Colin V; Brugières L; Reiter A; Cairo MS; Gross TG; Woessmann W; Burkhardt B; Sandlund JT; Williams D; Pillon M; Horibe K; Auperin A; Le Deley MC; Zimmerman M; Perkins SL; Raphael M; Lamant L; Klapper W; Mussolin L; Poirel HA; Macintyre E; Damm-Welk C; Rosolen A; Patte C
    J Clin Oncol; 2015 Sep; 33(27):2963-74. PubMed ID: 26304908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling Loss of Heterozygosity Patterns in a Cohort of Favorable Histology Nephroblastoma Egyptian Patients: What is Consistent With the Rest of the World.
    Fawzy M; Bahanassy A; Samir A; Hafez H
    Pediatr Hematol Oncol; 2015; 32(8):548-56. PubMed ID: 26390800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.